Nevro Corp. NVRO recently received CE Mark Certification in Europe for its HFX iQ spinal cord stimulation (SCS) system. The ...

AliveDx has obtained European In Vitro Diagnostic Device Regulation (IVDR) CE mark certification for its MosaiQ AiPlex CD ...

Nevro (NVRO) announced that it has received CE Mark Certification in Europe for its HFX iQ spinal cord stimulation system. The CE marking ...

Nevro (NVRO) announced that it has received CE Mark Certification in Europe for its HFX iQ spinal cord stimulation system. The CE marking allows Nevro to market HFX iQ in all countries that ...

The company announced receiving CE Mark Certification in Europe for its HFX iQ spinal cord stimulation system. Nevro raised ...

A key highlight of the quarter came right at the end when Nevro won FDA approval for HFX AdaptiveAI, an AI-powered, ...

Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the ...

the leading provider of patient-centric clinical-grade blood collection solutions, today announced it received CE Mark certification for its Tasso+™ device, a convenient, virtually pain-free ...

Detailed price information for Ventripoint Diagnostics Ltd (VPTDF) from The Globe and Mail including charting and trades.

Nov. 12, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, ...

("Ventripoint" or the "Company"), (TSXV:VPT; OTCQB:VPTDF) a leader in whole heart analysis technology, is pleased to announce CE Mark certification for its latest offering, VMS+4.0. This marks a ...

In addition to receiving CE marking, HFX iQ received U.S. Food and Drug Administration (FDA) approval in 2022. Nevro will offer the HFX iQ system in select European countries starting in the first ...